Camille Kotton | Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Massachusetts General Hospital

Camille Kotton, Clinical Director, Transplant and Immunocompromised Host Infectious Diseases, Massachusetts General Hospital

Camille Nelson Kotton MD, FIDSA, FAST is the Clinical Director of Transplant and Immunocompromised Host Infectious Diseases in the Infectious Diseases Division at the Massachusetts General Hospital. She spends the majority of her time seeing inpatients and outpatients, before and after solid organ and bone marrow transplant, as well as other immunocompromised hosts. Her interests include vaccination, travel medicine for transplant recipients, and reducing the infectious risks of immuncompromising medications. She has written numerous articles and chapters, and also speaks nationally and internationally on a regular basis. She is the past chair of the Infectious Disease Community of Practice, American Society of Transplantation, and is on the planning committee for the American Transplant Congress. She has excellent clinic flexibility and can often see transplant patients on a fairly immediate basis.


DC Co-conference Day 2 April 4 @ 12:40

A CMV vaccine based on non-replicating lymphocytic choriomeningitis virus vectors expressing gB and pp65

  • 12 months Phase I data supporting a Phase 2 randomized, placebo-controlled trial in CMV-negative recipient patients awaiting kidney transplantation from CMV-positive donors

back to speakers